Department of Clinical Studies and Surveillance
(CSS)

Mission

To conduct
clinical evaluations of antimalarial drugs and vaccines
against vector borne diseases (VBD), and to monitor and
evaluate the occurrence of VBD in order to optimise the
protection of Australian Defence Force personnel
against these diseases.

Objectives

Conduct clinical research activity on antimalarial
drugs.

Conduct clinical research activity on vaccines
against Japanese encephalitis and dengue.

Maintain the Central Malaria Register.

Provide clinical advice on VBD to ADF personnel.

Conduct epidemiological surveys of VBD.

Current Projects

Evaluation of tafenoquine for short duration
deployments.

Comparative evaluation of the safety and
tolerability of different courses of primaquine for
post exposure prophylaxis of malaria.

Evaluation of "risk perception" by ADF personnel on
compliance with primaquine post exposure prophylaxis of
malaria.

Evaluation of safety and tolerability of malarone
for malaria prophylaxis in an operational setting.